Peter Scott Chin, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 1,654 shares at $22.29 ($37K) on 2026-09-04, disclosed to the SEC on 2026-09-09.
Open-market sale of $37k DNLI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.